迪菲利克法林可以改善血液透析患者与有关的睡眠障碍
Daniel E Weiner1, Thilo Schaufler2, Kieran McCafferty3
1William B. Schwartz MD Division of Nephrology, Tufts Medical Center, Boston, MA, USA.
概括
迪菲利克法林有效地减少了患有慢性病相关的 (CKD-aP) 的血液透析 (HD) 患者的. 这种减少与患者睡眠质量的改善显著相关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 皮肤病学 皮肤病学
- 睡眠医学 睡眠医学
背景情况:
- 睡眠质量不佳是慢性病相关的 (CKD-aP) 患者的一个重要问题,影响死亡率和生活质量.
- 迪菲利克法林在接受血液透析 (HD) 的CKD-aP患者中减轻的效果已被证明是有效的.
研究的目的:
- 为了评估与difelikefalin实现的减少对中度至重度CKD-aP患者的睡眠质量的影响.
- 分析减少的强度和改善睡眠质量的相关性.
主要方法:
- 对第3期difelikefalin研究 (研究3105,KALM-1,KALM-2) 的一项特异性后期分析,涉及患有CKD-aP的患者接受HD.
- 的强度是使用最坏的强度数值评分尺度 (WI-NRS) 测量.
- 睡眠质量使用5D skala睡眠障碍问卷 (5-D SDQ) 和睡眠质量数值评分尺度 (SQ-NRS) 进行评估.
主要成果:
- 在WI-NRS中经历≥3点改善的患者在SQ-NRS和5-D SDQ上显示出明显更大的睡眠质量改善,而不是<3点改善的患者.
- 观察到WI-NRS和睡眠质量得分 (SQ-NRS和5-D SDQ) 在基线和第12周之间存在很高的相关性.
- 迪菲利克法林治疗导致更大程度的减少和随后的睡眠质量改善.
结论:
- 静脉注射difelikefalin减少与中度至重度CKD-aP患者的睡眠质量改善有关.
- 迪菲利克法林可以通过改善的缓解来改善睡眠质量来减轻CKD-aP的重大临床负担.
- 解决是提高整体福祉和潜在地减少CKD-aP患者的死亡率至关重要的.
更多相关视频
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.4K
07:04A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
Published on: August 19, 2018
10.6K
相关概念视频
01:27Dialysis
326
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
326
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
180
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
180
01:22Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
01:24Nephrotic Syndrome III : Nursing Management
15
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
15
01:25Hemodialysis I: Introduction
35
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
35
01:24Chronic Kidney Disease II: Clinical Manifestations
10
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
10